Evaluating AI Models and Predictors for COVID-19 Infection Dependent on Data from Patients with Cancer or Not: A Systematic Review
Korean J Clin Pharm 2024;34(3):141-154
Published online September 30, 2024
© 2024 Korean College of Clinical Pharmacy.
Takdon Kim1 and Heeyoung Lee2,3*
1Clinical Trials Center, Chungnam National University Hospital, Daejeon 35015, Republic of Korea
2College of Pharmacy, Inje University, Gimhae 50834, Republic of Korea
3Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae 50834, Republic of Korea
Correspondence to: Heeyoung Lee, College of Pharmacy, Inje University, Gimhae 50834, Republic of Korea
Tel: +82-55-320-3328, Fax: +82-55-320-3328, E-mail:
phylee1@inje.ac.kr Received May 3, 2024; Revised June 13, 2024; Accepted June 14, 2024.
This is an Open Access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (
http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.